​
​

Oculis (OCS) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

OCS Stock Forecast

Oculis stock forecast is as follows: an average price target of $33.50 (represents a 126.96% upside from OCS’s last price of $14.76) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

OCS Price Target

The average price target for Oculis (OCS) is $33.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $37.00 to $30.00. This represents a potential 126.96% upside from OCS's last price of $14.76.

OCS Analyst Ratings

Buy

According to 2 Wall Street analysts, Oculis's rating consensus is 'Buy'. The analyst rating breakdown for OCS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Oculis Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 11, 2024Yi ChenH.C. Wainwright--150.00%103.25%
Jun 10, 2024Colleen KusyRobert W. Baird--208.33%150.68%
Row per page
Go to

The latest Oculis stock forecast, released on Jun 11, 2024 by Yi Chen from H.C. Wainwright, set a price target of $30.00, which represents a 150.00% increase from the stock price at the time of the forecast ($12.00), and a 103.25% increase from OCS last price ($14.76).

Oculis Price Target by Period

1M3M12M
# Anlaysts--2
Avg Price Target--$33.50
Last Closing Price$14.76$14.76$14.76
Upside/Downside-100.00%-100.00%126.96%

In the current month, the average price target of Oculis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oculis's last price of $14.76. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2024Sandler O'NeillUnderperformUnderperformHold
Sep 24, 2024Sandler O'NeillUnderperformUnderperformHold
Aug 28, 2024H.C. WainwrightBuyBuyHold
Aug 21, 2024Sandler O'NeillUnderperformUnderperformHold
Jul 15, 2024Sandler O'NeillUnderperformUnderperformHold
Jun 21, 2024Sandler O'NeillUnderperformUnderperformHold
Jun 11, 2024H.C. WainwrightBuyBuyHold
Jun 11, 2024Bank of America SecuritiesBuyBuyHold
Row per page
Go to

Oculis's last stock rating was published by Sandler O'Neill on Oct 29, 2024. The company gave OCS a "Underperform" rating, the same as its previous rate.

Oculis Financial Forecast

Oculis Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Revenue-----------
Avg Forecast$191.72K$191.72K$191.72K$191.72K$230.32K$242.22K$244.67K$261.04K$240.26K$110.86K$175.07K
High Forecast$210.79K$210.79K$210.79K$210.79K$248.75K$266.31K$269.01K$287.01K$291.75K$121.89K$192.49K
Low Forecast$178.78K$178.78K$178.78K$178.78K$211.90K$225.87K$228.16K$243.42K$214.52K$103.38K$163.26K
# Analysts11114222522
Surprise %-----------

Oculis's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. OCS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Oculis EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
# Analysts11114222522
EBITDA-----------
Avg Forecast$-191.72K$-191.72K$-191.72K$-191.72K$-230.32K$-242.22K$-244.67K$-261.04K$-240.26K$-110.86K$-175.07K
High Forecast$-178.78K$-178.78K$-178.78K$-178.78K$-211.90K$-225.87K$-228.16K$-243.42K$-214.52K$-103.38K$-163.26K
Low Forecast$-210.79K$-210.79K$-210.79K$-210.79K$-248.75K$-266.31K$-269.01K$-287.01K$-291.75K$-121.89K$-192.49K
Surprise %-----------

undefined analysts predict OCS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Oculis's previous annual EBITDA (undefined) of $NaN.

Oculis Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
# Analysts11114222522
Net Income-----------
Avg Forecast$-17.10M$-17.10M$-17.10M$-17.10M$-16.87M$-18.93M$-16.87M$-14.88M$-16.82M$-13.28M$-10.55M
High Forecast$-15.60M$-15.60M$-15.60M$-15.60M$-15.57M$-17.27M$-15.39M$-13.58M$-16.42M$-12.12M$-9.62M
Low Forecast$-19.31M$-19.31M$-19.31M$-19.31M$-18.17M$-21.38M$-19.05M$-16.81M$-17.62M$-15.00M$-11.91M
Surprise %-----------

Oculis's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OCS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Oculis SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
# Analysts11114222522
SG&A-----------
Avg Forecast$1.68M$1.68M$1.68M$1.68M$2.02M$2.12M$2.14M$2.28M$2.10M$970.17K$1.53M
High Forecast$1.84M$1.84M$1.84M$1.84M$2.18M$2.33M$2.35M$2.51M$2.55M$1.07M$1.68M
Low Forecast$1.56M$1.56M$1.56M$1.56M$1.85M$1.98M$2.00M$2.13M$1.88M$904.68K$1.43M
Surprise %-----------

Oculis's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to OCS last annual SG&A of $NaN (undefined).

Oculis EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
# Analysts11114222522
EPS-----------
Avg Forecast$-0.42$-0.42$-0.42$-0.42$-0.42$-0.47$-0.42$-0.37$-0.41$-0.33$-0.26
High Forecast$-0.38$-0.38$-0.38$-0.38$-0.38$-0.43$-0.38$-0.33$-0.40$-0.30$-0.24
Low Forecast$-0.48$-0.48$-0.48$-0.48$-0.45$-0.53$-0.47$-0.41$-0.43$-0.37$-0.29
Surprise %-----------

According to undefined Wall Street analysts, Oculis's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OCS previous annual EPS of $NaN (undefined).

OCS Forecast FAQ

Is Oculis a good buy?

Yes, according to 2 Wall Street analysts, Oculis (OCS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of OCS's total ratings.

What is OCS's price target?

Oculis (OCS) average price target is $33.5 with a range of $30 to $37, implying a 126.96% from its last price of $14.76. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Oculis stock go up soon?

According to Wall Street analysts' prediction for OCS stock, the company can go up by 126.96% (from the last price of $14.76 to the average price target of $33.5), up by 150.68% based on the highest stock price target, and up by 103.25% based on the lowest stock price target.

Can Oculis stock reach $20?

OCS's average twelve months analyst stock price target of $33.5 supports the claim that Oculis can reach $20 in the near future.

What are Oculis's analysts' financial forecasts?

Oculis's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $978.26K (high $1.07M, low $909.35K), average EBITDA is $-978K (high $-909K, low $-1.071M), average net income is $-67.553M (high $-61.808M, low $-75.404M), average SG&A $8.56M (high $9.37M, low $7.96M), and average EPS is $-1.667 (high $-1.525, low $-1.86). OCS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $766.9K (high $843.18K, low $715.13K), average EBITDA is $-767K (high $-715K, low $-843K), average net income is $-68.389M (high $-62.388M, low $-77.232M), average SG&A $6.71M (high $7.38M, low $6.26M), and average EPS is $-1.687 (high $-1.539, low $-1.905).